CDKN2A and neoplasm: ANRIL is thought to regulate the INK4/ARF tumor suppressor locus [40, 41]; therefore, we examined expressions of two CDKN2A transcripts (p16INK4A and p14ARF) and one CDKN2B transcript (p15INK4B).